Prostate Clinical Trials

NRG-GU008

Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy (INNOVATE*)

More Information

NRG-GU009

Parallel Phase III Randomized Trials for High-Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT*)

More Information

NU 17U19

Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer

More Information

AR-V7

Prevalence of AR-V7 in African American Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Novel Hormonal Agents

Taste

Taste and Prostate Cancer

LGUCR

Louisiana Genitourinary Cancer Registry (LGUCR)

Genetics

Genetic Studies of Prostate Cancer

IRONMAN

Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)

More Information

Germline

Prostate Germline Consortium

Hoxton

A Phase 1 Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

More Information

PBP-301

SPLASH: Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using 177Lu-PNT2002 PSMA Therapy After Second-line Hormonal Treatment

More Information

PSMAddition

An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Clinical Trial Protocol CAAA617C12301

More Information